Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB vs RIVAROXABAN: Safety Overview

Metric RITUXIMAB RIVAROXABAN
Total FAERS Reports 178,614 131,274
Deaths Reported 28,910 19,233
Death Rate 16.2% 14.7%
Hospitalizations 54,631 70,513
Average Patient Age 54.6 yrs 70.0 yrs
% Female Patients 64.3% 47.7%
FDA Approval Date N/A Apr 10, 2025
Manufacturer Genentech, Inc. Macleods Pharmaceuticals Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription